U.S. Software Stock News

NYSE:UCB
NYSE:UCBBanks

A Look At United Community Banks (UCB) Valuation After Recent Choppy Share Price Moves

United Community Banks (UCB) is in focus after recent trading showed a mix of short term gains and pullbacks. This has prompted investors to reassess the stock’s valuation and performance across different time frames. See our latest analysis for United Community Banks. With the share price at US$33.56, recent trading has been choppy, with a 1-day share price return of a 1.12% decline contrasting with a 30-day share price return of 3.39%. The 1-year total shareholder return of 21.08% and...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Accelerated Royalty Deals and Dividend Hike Could Be A Game Changer For Royalty Pharma (RPRX)

Royalty Pharma plc recently reported first-quarter 2026 results showing revenue of US$631 million and net income of US$295 million, both higher than a year earlier, alongside continued share repurchases under its existing buyback program. Beyond the headline numbers, the company highlighted double-digit growth in recurring royalty receipts, increased its dividend, and committed over US$1.25 billion to new royalty and R&D funding deals, underscoring its role as a large-scale financier of...
NasdaqGS:INBX
NasdaqGS:INBXBiotechs

A Look At Inhibrx Biosciences (INBX) Valuation As Investors Await Phase 2 HexAgon Webcast Results

Inhibrx Biosciences (INBX) has drawn fresh attention after scheduling a May 11 webcast to share interim Phase 2 HexAgon data on its OX40 agonist INBRX-106 in first-line head and neck cancer. See our latest analysis for Inhibrx Biosciences. The webcast follows a sharp 30 day share price return of about 100% and a year to date gain of nearly 66%. However, the 1 day share price return shows a 12% decline, while the 1 year total shareholder return is around 10x. If this kind of clinical catalyst...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Why Beyond Meat (BYND) Is Down 9.3% After Q1 Results And Functional Beverage Pivot News

Beyond Meat has recently reported first-quarter 2026 results, with net revenues of US$58.21 million versus US$68.73 million a year earlier, and a reduced net loss of US$28.48 million, while also completing follow-on equity offerings and filing a US$10.40 million shelf registration tied to employee stock plans. Alongside cost cuts and lower cash use, the company is pivoting beyond plant-based meat into functional food and beverages, including its new Beyond Immerse protein drink distributed...
NYSE:PFSI
NYSE:PFSIDiversified Financial

A Look At PennyMac Financial Services (PFSI) Valuation After Strong Q1 Earnings And Capital Returns

PennyMac Financial Services (PFSI) drew fresh attention after first quarter 2026 results showed net income of US$82.32 million and higher earnings per share, alongside continued share buybacks and an affirmed quarterly dividend. See our latest analysis for PennyMac Financial Services. The stock has been under pressure, with a year to date share price return of negative 32.58% and a 1 year total shareholder return of negative 8.83%. However, the 3 year and 5 year total shareholder returns of...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

A Look At Qorvo (QRVO) Valuation After Earnings Beat And Share Repurchase Program

Qorvo (QRVO) has jumped onto investor radars after reporting quarterly results that beat revenue and adjusted EPS expectations, and after completing a large share repurchase that reduced outstanding stock during the period. See our latest analysis for Qorvo. Qorvo's latest beat on revenue and adjusted EPS, alongside the completed buyback, comes after a 14.39% 1 month share price return. The 1 year total shareholder return of 22.94% contrasts with weaker multi year results, suggesting...
NYSE:MH
NYSE:MHConsumer Services

A Look At McGraw Hill (MH) Valuation After Recent Share Price Rebound And Digital Revenue Progress

Stock performance snapshot and recent context McGraw Hill (MH) has drawn attention after recent trading, with the stock closing at $11.99 and showing a 2.39% gain over the past day, while month and past 3 months returns remain negative. See our latest analysis for McGraw Hill. That daily 2.39% share price return comes after a tougher period, with the 30 day share price return of 10.92% and year to date share price return of 26.67% both negative. This suggests momentum has been fading rather...
NYSE:JBTM
NYSE:JBTMMachinery

JBT Marel (JBTM) Is Up 16.9% After Q1 Profit Return And Reaffirmed 2026 Guidance

JBT Marel Corporation recently reported first-quarter 2026 results showing sales of US$936 million, a return to net income of US$45 million, and positive earnings per share from continuing operations, while reiterating full-year 2026 revenue and GAAP diluted EPS guidance. Alongside these financial updates, JBT Marel is pushing into the foodservice channel with its award-winning Fresh’n Squeeze 1800 Citrus Juicer, highlighting how its industrial processing expertise can be repurposed for...
NYSE:SKT
NYSE:SKTRetail REITs

How Investors Are Reacting To Tanger (SKT) Earnings Beat, Buybacks And Higher Full-Year EPS Guidance

In late April 2026, Tanger Inc. reported first-quarter results showing year-over-year increases in sales to US$143.54 million, revenue to US$150.42 million, and net income to US$28.26 million, while also completing a US$20.00 million repurchase of 589,622 shares and slightly raising its full-year diluted EPS guidance to US$1.05–US$1.13. Beyond the headline growth figures, the combination of higher quarterly earnings per share, an active buyback, and a guidance upgrade highlights Tanger’s...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

Laureate Education (LAUR) Is Up 6.9% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 Loss

Laureate Education, Inc. has reported past first-quarter 2026 results, with sales rising to US$272.61 million while its net loss widened to US$21.59 million, and the company has also issued second-quarter 2026 revenue guidance of US$597 million to US$601 million while reaffirming full-year expectations of about US$1.89 billion to US$1.91 billion. The combination of higher quarterly sales and reaffirmed full-year revenue guidance offers investors fresh information on how Laureate’s operations...
NYSE:VTR
NYSE:VTRHealth Care REITs

A Look At Ventas (VTR) Valuation After Raised 2026 Guidance And First Quarter Earnings

Guidance raise and first quarter earnings put Ventas in focus Ventas (VTR) raised its full year 2026 earnings guidance and reported first quarter results, highlighting higher property performance in its senior housing portfolio and contributions from recent investment activity. See our latest analysis for Ventas. After the guidance raise and first quarter results, Ventas’s recent share price moves tell a story of steady interest, with a 30 day share price return of 3.5%, year to date share...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

A Look At RadNet (RDNT) Valuation After Idaho Joint Venture And Upcoming Q1 Earnings

RadNet (RDNT) has drawn fresh attention after forming a joint venture with Saint Alphonsus Health System in Idaho, acquiring a majority stake in Intermountain Medical Imaging and preparing to report upcoming first quarter earnings. See our latest analysis for RadNet. Despite the Idaho joint venture and ongoing focus on AI-enabled imaging, RadNet’s share price return has been weak year to date, with a 19% decline and a 17% 3 month pullback, even as the 1 year total shareholder return is...
NYSE:COF
NYSE:COFConsumer Finance

A Look At Capital One Financial (COF) Valuation After Weak Q1 2026 Results And Lower Analyst Forecasts

Capital One Financial (COF) is back in focus after reporting Q1 2026 revenue and earnings below expectations, as rising loan-loss provisions and charge-offs highlighted mounting consumer stress and prompted several analysts to trim their forecasts. See our latest analysis for Capital One Financial. The stock’s recent pullback has been sharp, with a 22.32% year to date share price return decline and a 13.56% 3 month share price return decline. This comes even though the 3 year total...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

How Spectrum Mobile Second Line and New Product Leadership Will Impact Charter Communications (CHTR) Investors

Earlier this month, Charter Communications’ Spectrum brand launched Spectrum Mobile Second Line, a US$10-per-month add-on that lets eligible Dual SIM and dual eSIM smartphone users run two separate mobile numbers with shared data, unified billing, and full calling features across the U.S., Mexico, and Canada. A day earlier, Spectrum reshaped its product leadership by promoting long-time executive Dave Rodrian to Senior Vice President of Connectivity Products, consolidating oversight of...
NYSE:XYZ
NYSE:XYZDiversified Financial

A Look At Block’s (SQ) Valuation After AI-Led Restructuring And Upbeat First-Quarter 2026 Results

Block (XYZ) is back in focus after reporting first quarter 2026 results that topped profit forecasts, raised full year guidance, and highlighted cost savings from AI linked job cuts and restructuring. See our latest analysis for Block. Despite the latest 1-day share price return of around a 1% decline, Block’s 30-day and 90-day share price returns of 16.96% and 25.32% suggest momentum has picked up again. However, the 5-year total shareholder return of a 64.42% loss shows longer term holders...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

How Investors May Respond To Power Solutions International (PSIX) Data Center Capacity Misstatement Lawsuits

In recent months, multiple law firms have launched securities class action lawsuits against Power Solutions International, alleging false and misleading statements about its ability to meet data center sales demand and manage related manufacturing costs between May 2025 and March 2026. The wave of similar complaints highlights how disclosures about operational inefficiencies and gross margin pressure can rapidly shift legal, operational, and governance risks for shareholders. Next, we’ll...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Why NVIDIA (NVDA) Is Up 8.4% After New AI Infrastructure Alliances With IREN and Corning – And What's Next

In early May 2026, NVIDIA announced new alliances with IREN and Corning to deploy up to 5 gigawatts of DSX-aligned AI infrastructure and to massively expand U.S. production of advanced optical connectivity for next-generation AI data centers. These deals signal NVIDIA’s push to secure critical data center capacity and optical components, tightening its grip on the full AI factory supply chain from compute to connectivity. We’ll now examine how locking in large-scale DSX AI factories with...
NasdaqGS:MIDD
NasdaqGS:MIDDMachinery

A Look At Middleby (MIDD) Valuation After Recent Share Price Momentum

Middleby stock snapshot after recent performance Middleby (MIDD) has drawn investor attention after recent share price moves, with the stock up around 17% over the past month and roughly flat over the past 3 months. See our latest analysis for Middleby. The recent 11.0% 1 day share price return and 12.7% 7 day share price return suggest that short term momentum is picking up, while the 1 year total shareholder return of 13.4% points to steadier longer term progress. If the latest swing in...
NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp (RAMP) Valuation After Launch Of GPU Optimized AI Clean Rooms

LiveRamp Holdings (RAMP) recently introduced GPU-optimized clean rooms with native support for NVIDIA AI infrastructure, allowing AI partners and brands to train and deploy complex marketing models at significantly higher speeds while keeping underlying data and model weights protected. See our latest analysis for LiveRamp Holdings. The GPU clean room announcement comes on top of a strong run in the stock, with a 90 day share price return of 29.99% and a 1 year total shareholder return of...
NYSE:DELL
NYSE:DELLTech

Assessing Dell Technologies (DELL) Valuation After AI Push White House Backing And Texas Move

Dell Technologies (DELL) is back in the spotlight after three high profile developments: an expanded AI collaboration with Trust3 AI, a planned move of its legal home to Texas, and a public endorsement from the White House. See our latest analysis for Dell Technologies. The 1-day share price return of -3.57% comes after a sharp run, with a 30-day share price return of 29.59% and a 90-day share price return of 90.23%. The 1-year total shareholder return of 142.96% and 3-year total shareholder...
NYSE:RL
NYSE:RLLuxury

Earnings Surprises and Analyst Optimism Could Be A Game Changer For Ralph Lauren (RL)

In recent days, Ralph Lauren’s past two quarters of earnings have exceeded analyst expectations, with earnings per share coming in above forecasts and current analyst models pointing to the possibility of another outperformance in the upcoming report. This pattern of earnings surprises, combined with a positive Earnings ESP and shifting analyst rankings, is shaping how the market views Ralph Lauren’s near-term earnings potential and underlying business resilience. Next, we’ll examine how...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

How Investors Are Reacting To Cohu (COHU) Narrowing Losses, Stronger Q2 Sales Outlook, And Buybacks

Cohu, Inc. reported past first-quarter 2026 results with sales of US$125.12 million, a net loss of US$12.07 million, and issued second-quarter 2026 sales guidance of US$144 million plus or minus US$7 million while also confirming completion of its previously announced share repurchase program. The combination of higher year-on-year revenue, a smaller net loss, and quantified near-term sales expectations gives investors clearer insight into Cohu’s current operating trajectory and capital...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics (ADMA) Is Down 17.4% After FDA ASCENIV Pediatric Expansion And Legal Scrutiny - Has The Bull Case Changed?

In early May 2026, ADMA Biologics reported first-quarter revenue of US$114.49 million, essentially flat year on year, while net income rose to US$45.33 million and the FDA expanded ASCENIV’s indication to primary humoral immunodeficiency patients as young as two years old. At the same time, short-seller channel-stuffing allegations and multiple securities-law investigations have raised fresh questions about ADMA’s reported growth quality, governance, and future legal exposure. We’ll now...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Assessing Ascendis Pharma (ASND) Valuation After Recent Share Price Momentum

Ascendis Pharma (NasdaqGS:ASND) is back on investor radar after a recent share price move, with the stock up 4.3% over the past week and 0.3% year to date. See our latest analysis for Ascendis Pharma. The recent 7-day share price return of 7.31% and 1-day share price return of 4.34%, taking Ascendis Pharma to $246.14, point to momentum building after a relatively flat year-to-date share price return of 0.31%. If this kind of move has you looking beyond a single stock, it could be a good...